CIM
CRL icon

CenturyLink Investment Management’s Charles River Laboratories CRL Stock Holding History

CenturyLink Investment Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-16,712
Closed -$773K – 262
2013
Q3 		$773K Buy
+16,712
New +$767K 0.24% 152

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CenturyLink Investment Management's CRL Position: Q4 2013 in Review

CenturyLink Investment Management sold out of Charles River Laboratories (CRL) in Q4 2013, closing a stake of 16,712 shares — an estimated $773K sold.

CenturyLink Investment Management first reported a position in CRL in Q3 2013 and held it in 1 quarter. The position peaked at $773K in Q3 2013. 239 funds tracked by Wall St. Rank hold CRL as of Q4 2013.

  • CenturyLink Investment Management reported no remaining Charles River Laboratories position as of Q4 2013 after selling out during the quarter.
  • CenturyLink Investment Management sold 16,712 Charles River Laboratories shares in Q4 2013, an estimated $773K.
  • CenturyLink Investment Management first reported a position in Charles River Laboratories in Q3 2013 and held it in 1 quarter.
  • CenturyLink Investment Management's Charles River Laboratories position peaked at $773K in Q3 2013.
  • 239 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2013.

Based on CenturyLink Investment Management's 13F filing for Q4 2013, filed 10 Jan 2014.